Workflow
Heimdall Power
icon
Search documents
C3.ai Ramps Up Partner-Led Sales Model: Can It Drive Scalable Growth?
ZACKS· 2025-06-23 14:15
Key Takeaways C3.ai, Inc. (AI) is doubling down on a go-to-market strategy centered around its rapidly expanding partner ecosystem. In the fourth quarter of fiscal 2025, the company secured 73% of its agreements in collaboration with strategic partners like Microsoft, AWS and Google Cloud. In fiscal 2025, it signed 193 deals through the partner ecosystem, reflecting a rise of 68% from the prior year. In the fiscal fourth quarter, AI reported a 419% surge in partner-supported bookings, with 59 agreements clo ...
Best Growth Stocks to Buy for June 23rd
ZACKS· 2025-06-23 14:15
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today June 23rd: Strattec Security has a PEG ratio of 1.30 compared with 4.04 for the industry. The company possesses a Growth Score of A. European Wax Center (EWCZ) : This personal care franchise brand which offers wax services from certified Wax Specialists as well as full collection of proprietary products in the skincare, body and brow categories, carries a Zacks Rank #1, and has witnessed the Zacks Consensu ...
UGI's AmeriGas Propane to Divest Hawaii Assets by Fiscal Q4 2025
ZACKS· 2025-06-23 14:15
Key Takeaways UGI Corporation (UGI) announced that its subsidiary, AmeriGas Propane, L.P. (AmeriGas), has entered into a definitive agreement to divest some of its assets in Hawaii to Isle Gas, a wholly owned subsidiary of AMF Hawaii Investment Holdings, LLC, managed by Argo Infrastructure Partners. The transaction is expected to be closed in the fourth quarter of fiscal 2025, subject to customary closing conditions. What Are UGI's Gains From This Sale? Sempra Energy (SRE) is divesting certain assets as par ...
J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
ZACKS· 2025-06-23 14:15
Key Takeaways J&J (JNJ) announced that the EMA's Committee for Medicinal Products for Human Use ("CHMP") recommended granting label expansion to its two key products, Darzalex and Imbruvica, across separate new indications. CHMP Endorses JNJ's Darzalex for a New Multiple Myeloma Setting The EMA committee has issued a positive opinion for expanding Darzalex's label to treat adults with smoldering multiple myeloma (SMM), who are at high risk of developing multiple myeloma. If approved, the drug will be the fi ...
Accenture (ACN) Reliance on International Sales: What Investors Need to Know
ZACKS· 2025-06-23 14:15
Have you evaluated the performance of Accenture's (ACN) international operations for the quarter ending May 2025? Given the extensive global presence of this consulting company, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth. In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For inve ...
Insights Into Lindsay (LNN) Q3: Wall Street Projections for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, Lindsay (LNN) is predicted by Wall Street analysts to post quarterly earnings of $1.36 per share, reflecting a decline of 3.6% compared to the same period last year. Revenues are forecasted to be $162.01 million, representing a year-over-year increase of 16.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. It is projected by ...
Ahead of Nike (NKE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
The upcoming report from Nike (NKE) is expected to reveal quarterly earnings of $0.11 per share, indicating a decline of 89.1% compared to the year-ago period. Analysts forecast revenues of $10.67 billion, representing a decrease of 15.4% year over year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Ahead of a company's ...
Countdown to Acuity (AYI) Q3 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, Acuity (AYI) is predicted by Wall Street analysts to post quarterly earnings of $4.31 per share, reflecting an increase of 3.9% compared to the same period last year. Revenues are forecasted to be $1.14 billion, representing a year-over-year increase of 17.5%. The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this ...
Unlocking Q2 Potential of McCormick (MKC): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding. That said, let's delve into the average estimates of some McCormick metrics that Wall Street analysts commonly model and monitor. It is projected by analysts that the 'Net Sales- Flavor Solutions' will reach $746.82 million. The estimate points to a change of +1.1% from the ye ...
Unveiling Walgreens (WBA) Q3 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
In light of this perspective, let's dive into the average estimates of certain Walgreens metrics that are commonly tracked and forecasted by Wall Street analysts. The average prediction of analysts places 'Revenues- U.S. Retail Pharmacy' at $28.76 billion. The estimate indicates a year-over-year change of +0.9%. Analysts predict that the 'Revenues- U.S. Healthcare' will reach $2.17 billion. The estimate suggests a change of +2.3% year over year. The upcoming report from Walgreens Boots Alliance (WBA) is exp ...